The Monkey Soluble Intercellular Adhesion Molecule-1 (sICAM-1) ELISA quantitates Mk sICAM-1 in Monkey serum, plasma, cell culture supernatants, urine, amniotic fluid, bile, or other body fluids. The assay will exclusively recognize both natural and…
Accession number
Q5NKV6
Dose range
1.56-100 U/ml
Sensitivity of the dosage
1.05 U/ml
Conjugate
HRP
Product type
Kit ELISA
Brand
Invitrogen
The Monkey Soluble Intercellular Adhesion Molecule-1 (sICAM-1) ELISA quantitates Mk sICAM-1 in Monkey serum, plasma, cell culture supernatants, urine, amniotic fluid, bile, or other body fluids. The assay will exclusively recognize both natural and…
The Monkey Soluble Intercellular Adhesion Molecule-1 (sICAM-1) ELISA quantitates Mk sICAM-1 in Monkey serum, plasma, cell culture supernatants, urine, amniotic fluid, bile, or other body fluids. The assay will exclusively recognize both natural and recombinant Mk sICAM-1. Principle of the method The Monkey sICAM-1 solid-phase sandwich ELISA (enzyme-linked immunosorbent assay) is designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody has been pre-coated in the wells of the supplied microplate. Samples or controls are then added into these wells and bind to the immobilized (capture) antibody. The sandwich is formed by the binding of the second (detector) antibody to the target on a different epitope from the capture antibody. An antibody conjugated with enzyme binds the formed sandwich. After incubation and washing steps to rid the microplate of unbound substances, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.
The ICAML-1 (CD54) is a single chain type 1 integrated membrane glycoprotein of 85-110 kDa with an extracellular domain of five superfamily repeats of immunoglobulins, a transmembrane region, and a cytoplasmic domain. The ICAM-1 has 7 potential N-binding glycosylation sites and shares a significant amino acid sequence homology with ICAM-3 (CD50) and ICAM-2 (CD102). The ICAM-1 binds to CD11a/CD18 (leukocyte adhesion molecular, LFA-1) or CD11b/CD18 (Mac-1) integrins and is operated by Rhinovirus as a receptor. The ICAM-1 is expressed as activated endothelial cells detected on epithelial cells, fibroblasts, chondrocytes, B cells, T cells (low), monocytes, macrophages, dendritic cells and neutrophils, with relatively low levels that increase at the time of inflammation. L的ICAM-1 is also detected in some carcinomas and melanoma cells. Soluble L的ICAM 1 is detectable in plasma and is elevated in patients with various inflammatory syndromes.
Sensitivity
Sensitivity of the dosage: 1.05 U/ml.
Measurement range
Dosing range: 1.56-100 U/ml.
Duration of dosing
Total duration of dosing: 2 h 10 min.
Reproducibility
Coefficient of variation in intra-dose 10%, inter-dose 15%.